These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1317 related articles for article (PubMed ID: 1686599)
1. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle. Prusiner SB Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599 [TBL] [Abstract][Full Text] [Related]
10. BSE: can we predict the future? Plum J Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370 [TBL] [Abstract][Full Text] [Related]
11. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340 [TBL] [Abstract][Full Text] [Related]
12. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438 [TBL] [Abstract][Full Text] [Related]
13. Transmission barriers for bovine, ovine, and human prions in transgenic mice. Scott MR; Peretz D; Nguyen HO; Dearmond SJ; Prusiner SB J Virol; 2005 May; 79(9):5259-71. PubMed ID: 15827140 [TBL] [Abstract][Full Text] [Related]
14. The neuropathological phenotype in transgenic mice expressing different prion protein constructs. DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760 [TBL] [Abstract][Full Text] [Related]
15. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Collinge J; Palmer MS; Sidle KC; Hill AF; Gowland I; Meads J; Asante E; Bradley R; Doey LJ; Lantos PL Nature; 1995 Dec 21-28; 378(6559):779-83. PubMed ID: 8524411 [TBL] [Abstract][Full Text] [Related]
16. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues. Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541 [TBL] [Abstract][Full Text] [Related]
17. Early detection of PrPres in BSE-infected bovine PrP transgenic mice. Castilla J; Gutiérrez Adán A; Brun A; Pintado B; Ramírez MA; Parra B; Doyle D; Rogers M; Salguero FJ; Sánchez C; Sánchez-Vizcaíno JM; Torres JM Arch Virol; 2003 Apr; 148(4):677-91. PubMed ID: 12664293 [TBL] [Abstract][Full Text] [Related]
18. [A trend of molecular genetics on prion diseases and prion protein]. Muramatsu Y; Shinagawa M Nihon Rinsho; 1993 Sep; 51(9):2494-502. PubMed ID: 8411733 [TBL] [Abstract][Full Text] [Related]
19. Dominant-negative inhibition of prion replication in transgenic mice. Perrier V; Kaneko K; Safar J; Vergara J; Tremblay P; DeArmond SJ; Cohen FE; Prusiner SB; Wallace AC Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13079-84. PubMed ID: 12271119 [TBL] [Abstract][Full Text] [Related]
20. Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells. Priola SA; Caughey B; Raymond GJ; Chesebro B Infect Agents Dis; 1994; 3(2-3):54-8. PubMed ID: 7812655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]